Patient Resources / About Radiotherapeutics
A more targeted kind of radiation.
If you or someone you love is facing cancer in the brain or spinal cord, “radiotherapeutic” may be a new word. It’s radiation that travels directly to the tumor, so less reaches healthy tissue nearby.
A different way in.
Radiation usually reaches a tumor from outside the body, passing through healthy tissue on the way. A targeted radiotherapeutic starts at the tumor itself, which changes how it’s given and how it’s being studied.
Instead of aiming radiation at a tumor from outside the body, a radiotherapeutic delivers it from within, right at the tumor. Cerenome’s radiotherapeutics use a form of the element rhenium (rhenium-186), which does two things at once:
Beta energy
Treats the tumor. Rhenium-186 releases beta energy that travels only about a millimeter or two. That short range concentrates the treatment on the tumor while limiting the dose to the healthy tissue around it.
Gamma energy
Lets the team watch in real time. It also releases gamma energy that can be imaged during treatment. The care team can see where the radiation went, rather than assuming.
What that can mean for you
Affecting less healthy tissue may mean fewer side effects, which is an important part of quality of life during treatment. These treatments and their benefits are still being studied.
Vs. chemotherapy
Chemotherapy travels through the whole body. A targeted radiotherapeutic is designed to concentrate at the tumor.
Vs. traditional radiation
Very low doses of external radiation pass through healthy tissue to reach a tumor. A targeted radiotherapeutic works from inside, at the tumor, so it doesn’t have to.
How Cerenome is working on it.
Cerenome’s targeted radiotherapeutic, REYOBIQ™—an investigational treatment—is being studied in clinical trials called ReSPECT™, in recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer. How it’s given depends on the cancer: either directly into the tumor with a method known as convection-enhanced delivery (CED) or into the CSF via an Ommaya reservoir, in an inpatient or outpatient setting depending on the tumor type.
These are investigational uses. The treatment is still being studied, and its safety and effectiveness have not been established. Your care team is the best guide to whether a clinical trial may be right for you.
Support & Resources
Where to learn more.
Questions to ask your care team
- Could a targeted radiotherapy trial be an option for my diagnosis?
- What would taking part involve, and what are the possible risks and benefits for me?
- How would the treatment be given, and what should I expect?
Where to find support
- American Brain Tumor Association
- American Cancer Society
- Brain Tumor Network
- Dictionary of Cancer Terms
- End Brain Cancer Initiative
- Head for the Cure
- Leptomeningeal Cancer Foundation
- LUNGevity
- MedlinePlus (NIH)
- METAvivor
- National Brain Tumor Society
- National Cancer Institute
- National Comprehensive Cancer Network
- Support Groups Listing
- The Brain Tumour Charity
- VirtualTrials.org